Visit the ACCC COVID-19 Resource Center & Discussion Group for Insights on Providing Optimal Patient Care During the Pandemic.
 

Overview

Multidisciplinary Advanced Cutaneous Squamous Cell Carcinoma Care

Cutaneous squamous cell carcinoma (cSCC), a cancer arising from malignant proliferation of epidermal keratinocytes,1 is the second most common skin cancer in the United States (after basal cell carcinoma), representing 20 - 50 percent of skin cancers.1 This cancer can develop on multiple skin surfaces, including the head, neck, trunk, extremities, oral mucosa, periungual skin, and anogenital areas.2  

Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) together account for the vast majority of the skin cancers in the U.S. Of the two, BCC is far more common. (According to the American Cancer Society, of the estimated 3.3 million new cases of BCC and SCC diagnosed each year in the U.S., 8 out of 10 are BCC.)3  Thus, providers in the community setting are less likely to diagnose and treat patients with advanced cutaneous squamous cell carcinoma (cSCC) on a regular basis. 

BCC rarely metastasizes; in contrast, 2 - 5 percent of cSCCs metastasize to regional lymph nodes or more distant sites.4 Although mortality for SCC is low, there can be significant morbidity associated with this disease, as well as a high cost of care, creating a significant risk to the patient’s quality of life.  

1. Que SK, Zwald F, Schmults C. Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging, 2018. J Am Acad Dermatol. 2018;78.2:237-47.
2. 
Lim JL, Asgari M. Epidemiology and risk factors for cutaneous squamous cell carcinoma. UpToDate. (Last updated Sept. 2018) Available at UptoDate.com/contents/epidemiology-and-riskfactors-for-cutaneous-squamous-cell-carcinoma. Accessed Dec. 6, 2018.
3. American Cancer Society. Key statistics for basal and squamous cell carcinoma. Available online at www.cancer.org/cancer/basal-and-squamous-cell-skin-cancer/about/key-statistics.html. Accessed Dec. 6, 2018.
4. Aasi SZ, Hong A. Treatment and prognosis of low-risk cutaneous squamous cell carcinoma. (Last updated Nov. 2018) Accessed Dec. 6, 2018. Available at www.uptodate.com/contents/treatment-and-prognosis-of-low-risk-cutaneous-squamous-cell-carcinoma.

Project Goal

For the Multidisciplinary Advanced Cutaneous Squamous Cell Carcinoma Care project, ACCC will provide examples of effective practices in diagnosing, testing, and treating this patient population to advance comprehensive care for people with cSCC.

Specifically, this project will provide:

  • expert insights provided by the project's experienced advisory committee in curating all project resources developed in support of education and awareness for cSCC.
  • a hub of resources for the multidisciplinary cancer care team.
  • a case studies publication that highlights effective practices in meeting the needs of this patient population.
  • live regional lecture series to facilitate peer-to-peer learning, expand local resources, and discuss the latest treatment techniques. 
For questions or more information, please email Monique Dawkins, EdD, MPA, Assistant Director, ACCC Provider Education. 
 

Publication Cover ThumbnailMultidisciplinary Advanced Cutaneous Squamous Cell Carcinoma Care

Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer in the U.S.; however, optimal identification and management of patients with high-risk features associated with recurrence or advanced cSCC can be complex and requires the expertise of multiple specialists. 

This publication maps out effective practices in multidisciplinary cSCC management. Included are three care models from regionally diverse cancer programs located in areas of high cSCC prevalence.

ACCC thanks the following Cancer Program Members for their contributions to this publication:

Ellis Fischel Cancer Center
Columbia, Missouri

The George Washington University Cancer Center
Washington, D.C.

The Knight Cancer Institute
Portland, Oregon

Read the ACCC press-release:

Association of Community Cancer Centers Project Focuses on Multidisciplinary Cutaneous Squamous Cell Carcinoma Care
Dec 2, 2019

Rockville, MD – Due to the rarity of advanced cutaneous squamous cell carcinoma (cSCC), staying current with the latest information on diagnosing, treating, and supporting patients with this diagnosis can be challenging for clinicians who do not often encounter advanced cSCC in practice. To support the multidisciplinary cancer team in treating patients with cSCC, the Association of Community Cancer Centers (ACCC)—in partnership with the AIM at Melanoma Foundation (AIM)—has developed resources through its Multidisciplinary Cutaneous Squamous Cell Carcinoma Care education project. Under the guidance of an expert advisory committee—ACCC has created a robust compendium of resources, peer-to-peer learning opportunities, and real-world examples of effective practices in diagnosing, testing, and treating this patient population.
Read More

Our Partner

SKIN-cancer-201x80 

Our Supporters

logo-Regeneron-200x80 sanofi-110x87
This project is sponsored by Regeneron and Sanofi.